Free Newsletter
Confused jury prompts Wyeth appeal
Was the jury confused? Apparently so. When a Nevada jury decided in favor of three women who claimed that the company's hormone replacement drugs caused their breast cancer, some jurors thought the $134.5 million awarded included punitive damages. It didn't.
The judge sent the jury back to the drawing board. Compensatory damages: $35 million. After the subsequent punitive phase, the jury tacked on another $99 in punitive damages. No harm, no foul? Not so fast. Wyeth says the confusion strengthens its inevitable appeal.
- see Wyeth's release
- check out the article from CNN Money
Related Articles:
Jury fines Wyeth $134.5M in hormone suit. Report
Jurors deliberate in Prempro trial. Report
Wyeth want end to customized HRT treatments. Report
HRT doesn't protect women from heart disease. Report
Read more on: Wyeth
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage


